- Report
- November 2024
- 93 Pages
Asia Pacific
From €3095EUR$3,450USD£2,700GBP
- Report
- May 2024
- 209 Pages
Global
From €3993EUR$4,450USD£3,482GBP
- Report
- January 2024
- 150 Pages
Global
From €4352EUR$4,850USD£3,795GBP
- Report
- January 2024
- 150 Pages
Global
From €4352EUR$4,850USD£3,795GBP
- Report
- October 2024
- 80 Pages
Global
From €8968EUR$9,995USD£7,821GBP
- Report
- February 2025
- 130 Pages
Global
From €4352EUR$4,850USD£3,795GBP
- Report
- January 2022
- 278 Pages
Global
From €3241EUR$3,613USD£2,827GBP
€3813EUR$4,250USD£3,326GBP
- Report
- July 2023
- 102 Pages
Global
From €3500EUR$4,179USD£3,159GBP
- Report
- April 2026
- 50 Pages
Global
From €2378EUR$2,650USD£2,074GBP
- Report
- April 2026
- 50 Pages
Global
From €2378EUR$2,650USD£2,074GBP
- Report
- April 2026
- 50 Pages
Global
From €2378EUR$2,650USD£2,074GBP
- Report
- November 2021
- 600 Pages
Global
From €3589EUR$4,000USD£3,130GBP

Morphine is an analgesic drug used to treat moderate to severe pain. It is a member of the opioid family, and is derived from the opium poppy plant. Morphine is available in a variety of forms, including tablets, capsules, syrups, and injectable solutions. Morphine is often used in the treatment of cancer pain, post-operative pain, and chronic pain. It is also used to treat acute pain, such as that caused by a heart attack or stroke. Morphine is generally considered to be a safe and effective analgesic, but it can cause side effects such as nausea, vomiting, constipation, and drowsiness.
Morphine is available in both generic and brand-name formulations. Some of the major companies in the market include Purdue Pharma, Endo Pharmaceuticals, Teva Pharmaceuticals, and Mylan Pharmaceuticals. Show Less Read more